Skip to content

Public FDA record

Z-1107-2020: VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit

Recall record Z-1107-2020 for bioMerieux, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1107-2020
Company in FDA record
bioMerieux, Inc.
FDA record creation date
Feb 7, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result.

Source facts

Action
Users are instructed via customer letter to stop using the VIDAS VZG batches 1007410330 and 1007393380 and destroy the remaining products.
Initiated
2019-12-10
Root cause
Unknown/Undetermined by firm
Terminated
2021-02-16
Distribution
Distributed nationwide and 9 units to Biomerieux Canada.
Recall number
Z-1107-2020
Recall status
Terminated
CDRH record ID
178325
FDA record created
2020-02-07
Recall event number
84439

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗